English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 906805 線上人數 : 939
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
搜尋範圍
全部NHRI
生技與藥物研究所
張竣評
--專利
--會議論文/會議摘要
--期刊論文
查詢小技巧:
您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
進階搜尋
主頁
‧
登入
‧
上傳
‧
說明
‧
關於NHRI
‧
管理
國家衛生研究院 NHRI
>
生技與藥物研究所
>
張竣評
>
依題名瀏覽
依作者瀏覽
依日期瀏覽
依資料類型瀏覽
社群詳細資訊
簡介:
NA
資料載入中.....
子類別
專利
[
0
/3]
會議論文/會議摘要
[
0
/2]
期刊論文
[
21
/21]
鄰近社群
伍素瑩
[
52
/65]
其他
[
58
/60]
夏克山
[
76
/98]
岳嶽
[
29
/32]
張仲明
[
7
/9]
張俊彥
[
18
/18]
徐祖安
[
170
/215]
李秀珠
[
75
/105]
李靜琪
[
23
/24]
林書玉
[
19
/20]
洪明秀
[
31
/40]
潘秀玲(2009-2013)
[
16
/17]
王文傑
[
13
/15]
王鴻俊
[
7
/7]
石全(2014-2017)
[
35
/39]
童俊維
[
23
/23]
紀雅惠
[
21
/25]
翁紹華
[
22
/24]
莊宏
[
1
/1]
葉修華
[
24
/25]
葉燈光
[
133
/152]
蔣維棠
[
41
/66]
謝興邦
[
171
/231]
趙宇生(2002-2013)
[
120
/212]
郭靜娟
[
49
/55]
鄒倫
[
28
/29]
陳志豪
[
31
/52]
陳新(2002-2015)
[
53
/67]
陳炯東
[
180
/212]
顏婉菁
[
6
/7]
許明珠(1997-2001)
[
3
/10]
陳淑貞(1998-2001)
[
3
/11]
陳華鍵(1997-2001)
[
9
/9]
社群統計
近3年內發表的文件:3(11.54%)
含全文筆數:21(80.77%)
文件下載次數統計
下載大於0次:21(100.00%)
下載大於100次:19(90.48%)
檔案下載總次數:12149(0.23%)
最後更新時間: 2024-12-01 03:19
上傳排行
資料載入中.....
下載排行
資料載入中.....
最近上傳
Discovery of a long half-life AURKA...
Pulmonary delivery of remdesivir an...
Modulating the affinity and signali...
Synergistic inhibition of SARS-CoV-...
Discovery and synthesis of a pyrimi...
Synergistic inhibition of SARS-CoV-...
BPR6K609: An Aurora kinase inhibito...
Inhibition of SARS-CoV-2 by highly ...
Comparative study between deep lear...
An Aurora kinase inhibitor BPR6K471...
跳至:
(選擇年份)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(選擇月份)
January
February
March
April
May
June
July
August
September
October
November
December
或輸入年份:
由新到舊排序
由最舊的開始
顯示項目1-26 / 26. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
日期
題名
關聯
2024-06-01
Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus
Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
2023-12
Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced inflammatory suppression in lung
Journal of Drug Delivery Science and Technology. 2023 Dec;90:Article number 105144.
2023-01
Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists
Bioorganic Chemistry. 2023 Jan;130:Article number 106236.
2021-06-11
Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir[Erratum:ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.]
ACS Pharmacology and Translational Science. 2021 Jun 11;4(3):Article number 1246.
2021-05-19
Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins
Journal of Medicinal Chemistry. 2021 May 19;64(11):7312-7330.
2021-04-09
Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir
ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.
2020-12-14
Inhibition of SARS-CoV-2 by highly potent broad-spectrum anti-coronaviral tylophorine-based derivatives
Frontiers in Pharmacology. 2020 Dec 14;11:Article number 606097.
2020-10-08
Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery
Scientific Reports. 2020 Oct 8;10:Article number 16771.
2020-08
BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification
Cancer Research. 2020 Aug;80(16):1937.
2019-07
An Aurora kinase inhibitor BPR6K471 inhibits tumor growth and reduces the cancer stem cell-like properties of small cell lung cancer
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 3851.
2019-01-01
Fluorine-18 isotope labeling for positron emission tomography imaging. Direct evidence for DBPR211 as a peripherally restricted CB1 inverse agonist
Bioorganic and Medicinal Chemistry. 2019 Jan 1;27(1):216-223.
2018-05-10
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition
European Journal of Medicinal Chemistry. 2018 May 10;151:533-545.
2016-12-08
Bromomethylthioindole inspired carbazole hybrids as promising class of anti-MRSA agents
ACS Medicinal Chemistry Letters. 2016 Dec 8;7(12):1191-1196.
2015-05
A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis
Diabetes, Obesity and Metabolism. 2015 May;17(5):495-504.
2015-03
Stem cell mobilizers targeting chemokine receptor CXCR4: Renoprotective application in acute kidney injury
Journal of Medicinal Chemistry. 2015 Mar;58(5):2315-2325.
2015-02-24
Pyrazole compounds
US8962845/2015-02-24
2015-02-11
吡唑類化合物
I472514/2015-02-11
2015-02
Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors
Journal of Medicinal Chemistry. 2015 Feb;58(3):1452-1465.
2014-07-30
Pyrazole compounds
ZA201303800B/2014-07-30
2013-11-13
Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice
Journal of Medicinal Chemistry. 2013 Nov 13;56(24):9920-9933.
2012-07
Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors
International Journal of Obesity. 2012 Jul;36(7):999-1006.
2012-02
Discovery of novel stem cell mobilizers that target the CXCR4 receptor
ChemMedChem. 2012 Feb;7(2):209-212.
2011-07
Conia-ene annulation of the alpha-cyano Beta-TMS-capped alkynyl cycloalkanone system and its synthetic application
Organic and Biomolecular Chemistry. 2011 Jul;9(13):4778-4781.
2010-09
Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophe n-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist
ChemMedChem. 2010 Sep;5(9):1439-1443.
2009-07-23
Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice
Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4496-4510.
2008-09-11
Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antagonists
Journal of Medicinal Chemistry. 2008 Sep 11;51(17):5397-5412.
顯示項目1-26 / 26. (共1頁)
1
每頁顯示[
10
|
25
|
50
]項目
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
回饋